Infliximab in the treatment of steroid-dependent ulcerative colitis.

Author: ArmuzziA, De PascalisB, FedeliP, GasbarriniA, GasbarriniG, LeoD, LupascuA, MelinaD, MentellaM C, PolaP, VincentiF

Paper Details 
Original Abstract of the Article :
BACKGROUND AND OBJECTIVES: Infliximab has proven efficacious in the treatment of Crohn's disease. Limited and contrasting data are available on effectiveness of anti-TNF alpha therapy in ulcerative colitis. We evaluated the efficacy of infliximab in the management of steroid-dependent ulcerative col...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/15638236

データ提供:米国国立医学図書館(NLM)

Infliximab in the Treatment of Steroid-Dependent Ulcerative Colitis

Ulcerative colitis (UC), a chronic inflammatory bowel disease, often requires long-term treatment and management. This research explores the effectiveness of infliximab, a medication that blocks the action of TNF-alpha, in treating steroid-dependent UC. The study, a randomized controlled trial, compared infliximab to methylprednisolone in inducing and maintaining remission in patients with moderate to severe steroid-dependent UC. The findings suggest that infliximab is as effective as steroids in achieving remission and potentially offers a viable alternative for managing steroid-dependent UC, providing a potentially safer and more effective long-term treatment option.

A New Path Through the Desert of Ulcerative Colitis

This research, like a new caravan route across the vast desert of UC treatment, explores the potential of infliximab as a viable alternative to steroids. The findings, similar to a well-stocked oasis discovered in the desert, offer hope for a more effective and potentially safer treatment option for patients with steroid-dependent UC.

Navigating the Challenges of Ulcerative Colitis Treatment: Infliximab

Imagine a desert traveler seeking a more sustainable way to journey through the harsh landscape. Infliximab, like a sturdy camel adapted to the desert environment, offers a potential solution for individuals struggling with steroid-dependent UC. This research provides valuable information about the effectiveness and safety of infliximab, offering a new path towards long-term remission and improved quality of life for patients with UC.

Dr. Camel's Conclusion

This research, like a caravan traversing the desert of UC treatment, explores the potential of infliximab as a promising alternative to steroids. The findings suggest that infliximab offers a potentially safer and more effective long-term treatment option, offering hope for improved outcomes for individuals living with UC.

Date :
  1. Date Completed 2005-02-04
  2. Date Revised 2022-04-09
Further Info :

Pubmed ID

15638236

DOI: Digital Object Identifier

15638236

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.